Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited is a major Chinese pharmaceutical company founded in 1997 and headquartered in Guangzhou, China[1][2]. The company engages in the research, development, manufacturing, and sales of various pharmaceutical products, including Chinese and Western patent medicines, active pharmaceutical ingredients (APIs), and healthcare products[2]. ## Key Information - **Industry**: Pharmaceuticals, Medicinal Chemical & Botanical Products[1] - **Founded**: 1997[1] - **Location**: Guangzhou, China[1] - **Ownership**: State-owned enterprise[2] ## Business Operations Guangzhou Baiyunshan's main activities include: 1. Research and development of pharmaceuticals 2. Manufacturing of Chinese and Western medicines 3. Production of chemically active pharmaceutical ingredients (APIs) 4. Development and sales of healthcare products 5. Wholesale, retail, import, and export of pharmaceutical products and medical devices[2] The company is one of the largest healthcare companies in China, with a diverse portfolio spanning traditional Chinese medicine, Western medicine, and medical devices[2]. ## Management The company's management team includes: - Yang Jun: Director and Vice Chairperson[3] - Liu Juyan: Director, Deputy General Manager, and Chief Engineer of GPHL[3] - Li Hong: Director[3] - Zheng Haoshan: Deputy General Manager[3] ## Financial Performance In 2022, Guangzhou Baiyunshan's revenue growth stagnated[1]. The company is listed on the Hong Kong Stock Exchange under the ticker 0874.HK[5][6]. Guangzhou Baiyunshan operates in a critical sector of China's healthcare industry, combining traditional Chinese medicine with modern pharmaceutical practices to serve a wide range of medical needs. Citations: [1] https://www.statista.com/companies/o/25120335/guangzhou-baiyunshan [2] https://www.weforum.org/organizations/guangzhou-pharmaceutical-holdings/ [3] https://www.gybys.com.cn/article/45.html [4] https://synapse.patsnap.com/organization/b84e3bb9eea3d40bb097fdd8b9524bf6 [5] https://consent.yahoo.com/v2/collectConsent [6] https://www.google.com/finance/quote/0874:HKG?hl=ko [7] https://www.reuters.com/markets/companies/0874.HK/ [8] https://www.forbes.com/companies/guangzhou-baiyunshan-pharmaceutical-holdings/